Stocks With Heavy Insider Buying Last Week

Page 1 of 2

Insider buying: Most investors misunderstand the term insider trading. Of the thousands of SEC-filed transactions that corporate insiders engage in every year, just a few are deemed illegal by federal prosecutors.  Within this universe of legal insider trades, it’s much more important to track insider buying versus selling activity.

As the old adage goes, there are many reasons for an exec to sell shares of his or her company, but only one, very bullish reason why they would buy (discover how some investors beat the market by following insiders). With that being said, let’s take a look at some of the most important insider buys over the past week.

Raj Rajaratnam thinking

Last Tuesday, the CEO and CFO of Scotts Miracle-Gro Co (NYSE:SMG) both reported purchasing shares of their company’s stock at an average price near $49.50. CEO James Hagedorn increased his direct stake in Scotts ever so slightly to 35,000 shares, and Executive VP/CFO Lawrence Hilsheimer bought at a similar price to increase his holdings to almost 1,000 shares. Since the day both insider buys were reported publicly, shares of Scotts are up 1.5%, and both execs have already booked a 12% gain on their latest trades.

Cable software provider BroadSoft Inc (NASDAQ:BSFT), meanwhile, saw board member Charles L. III snatch up more than $17,000 worth of his company’s stock last week. The director’s position in BroadSoft is now worth more than $350,000 at current market prices, and his latest trade marks his sixth buy since May. In March of this year, fellow director John Markley Jr. bought in when BroadSoft traded near $23 a share; the stock closed last week above the $36 mark.

In another bout of insider bullishness, Pulaski Financial Corp (NASDAQ:PULB) saw three board members buy stock at an average purchase price near $10.20 a piece. Shares of the small-cap bank holding company were up almost 3% last week on the news. Generally speaking, the greatest potential for market outperformance occurs when three or more insiders buy shares within a period of a few months. With multiple buys in the span of one day, Pulaski Financial is worth watching very closely moving forward.

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!